GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Corp (SHSE:603716) » Definitions » Total Assets

Thalys Medical Technology Group (SHSE:603716) Total Assets : ¥3,134 Mil (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group Total Assets?

Thalys Medical Technology Group's Total Assets for the quarter that ended in Sep. 2024 was ¥3,134 Mil.

Warning Sign:

If a company builds assets at 11% a year, faster than its revenue growth rate of 9% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Thalys Medical Technology Group's average Total Assets Growth Rate was -16.40% per year. During the past 3 years, the average Total Assets Growth Rate was -2.30% per year. During the past 5 years, the average Total Assets Growth Rate was 11.00% per year. During the past 10 years, the average Total Assets Growth Rate was 28.70% per year.

During the past 13 years, Thalys Medical Technology Group's highest 3-Year average Total Assets Growth Rate was 50.10%. The lowest was -2.30%. And the median was 25.20%.

Total Assets is connected with ROA %. Thalys Medical Technology Group's annualized ROA % for the quarter that ended in Sep. 2024 was -6.46%. Total Assets is also linked to Revenue through Asset Turnover. Thalys Medical Technology Group's Asset Turnover for the quarter that ended in Sep. 2024 was 0.14.


Thalys Medical Technology Group Total Assets Historical Data

The historical data trend for Thalys Medical Technology Group's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thalys Medical Technology Group Total Assets Chart

Thalys Medical Technology Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,007.06 3,948.92 4,293.57 3,958.81 3,341.78

Thalys Medical Technology Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,752.69 3,341.78 3,306.19 3,208.20 3,134.27

Thalys Medical Technology Group Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Thalys Medical Technology Group's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1314.692+2027.092
=3,342

Thalys Medical Technology Group's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=1144.854+1989.415
=3,134

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thalys Medical Technology Group  (SHSE:603716) Total Assets Explanation

Total Assets is connected with ROA %.

Thalys Medical Technology Group's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-205.012/( (3208.197+3134.269)/ 2 )
=-205.012/3171.233
=-6.46 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Thalys Medical Technology Group's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=444.424/( (3208.197+3134.269)/ 2 )
=444.424/3171.233
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Thalys Medical Technology Group Total Assets Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Thalys Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
Executives
Wang Jun Ming senior management
Wang Zheng senior management
Wang Wen Bin senior management
Liu Wen Hao Director
Huang Yong Xi senior management
Lei Xian Kun Director
Fan Li Director
Liu Yuan senior management
Wan Li Bo senior management
Wen Wei Director
Chou Jian senior management
Song Yu Director

Thalys Medical Technology Group Headlines

No Headlines